Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker [version 2; peer review: 1 approved, 2 approved with reservations]
Background Changes in blood transcript abundance levels have been associated with pathogenesis in a wide range of diseases. While next generation sequencing technology can measure transcript abundance on a genome-wide scale, downstream clinical applications often require small sets of genes to be se...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
F1000 Research Ltd
2024-04-01
|
| Sarja: | F1000Research |
| Aiheet: | |
| Linkit: | https://f1000research.com/articles/11-1294/v2 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|